Academic Journal

The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma

التفاصيل البيبلوغرافية
العنوان: The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma
المؤلفون: Gian Paolo Caviglia, Maria Lorena Abate, Emanuela Rolle, Patrizia Carucci, Angelo Armandi, Chiara Rosso, Antonella Olivero, Davide Giuseppe Ribaldone, Francesco Tandoi, Giorgio Maria Saracco, Alessia Ciancio, Elisabetta Bugianesi, Silvia Gaia
المصدر: Biology, Vol 10, Iss 3, p 215 (2021)
بيانات النشر: MDPI AG, 2021.
سنة النشر: 2021
المجموعة: LCC:Biology (General)
مصطلحات موضوعية: BCLC, biomarker, ERBB3, HCC, Biology (General), QH301-705.5
الوصف: Epidermal growth factor receptor 3 (ERBB3) is a surface tyrosine kinase receptor belonging to the EGFR/ERBB family, involved in tumor development and progression. We evaluated the diagnostic and prognostic value of serum ERBB3 measurement in hepatitis C virus (HCV)-infected patients with early hepatocellular carcinoma (HCC). A total of 164 HCV-infected patients (82 with cirrhosis and 82 with early HCC) were included in the study. HCC was classified according to the Barcelona Clinic Liver Cancer (BCLC) staging system. Among patients with HCC, 23 (28%) had a diagnosis of very early tumor (BCLC = 0), while 59 (62%) had a diagnosis of early HCC (BCLC = A). Median overall survival (OS) in patients with HCC was 79.2 (95% CI 51.6–124.8) months. While ERBB3 serum values were similar between patients with cirrhosis and those with HCC (p = 0.993), in the latter, serum ERBB3 ≥ 2860 RU resulted significantly and independently associated with OS (Hazard Ratio = 2.24, 95% CI 1.16–4.35, p = 0.017). Consistently, the 1-, 3-, and 5-year OS rates in patients with serum ERBB3 ≥ 2860 RU were 90% (36/40), 53% (19/36), and 28% (8/29) in comparison to patients with serum ERBB3 < 2860 RU, which were 98% (40/41), 80% (32/40), and 74% (26/35) (Log-rank test; p = 0.014). In conclusion, serum ERBB3 values resulted an independent prognostic factor of patients with early HCC and might be useful to tailor more personalized treatment strategies.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2079-7737
Relation: https://www.mdpi.com/2079-7737/10/3/215; https://doaj.org/toc/2079-7737
DOI: 10.3390/biology10030215
URL الوصول: https://doaj.org/article/ba11b04059cc4e93894956095dd27a01
رقم الانضمام: edsdoj.ba11b04059cc4e93894956095dd27a01
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20797737
DOI:10.3390/biology10030215